Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Benjamin Berger

7PUBLICATIONS

12CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsPharmacogenomicsCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 27, 2024

Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A.

Massimo Magliocca, Benjamin Berger, Vincent Lemoine

|Oct 06, 2023

Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects.

Benjamin Berger, Priska Kaufmann, Matthias Berse

|Apr 12, 2023

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT-1014-6470 in vitro and in vivo.

Marion Anliker-Ort, Jasper Dingemanse, Stephane Delahaye

|Jun 14, 2021

Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment.

Benjamin Berger, Clemens Muehlan, Gernot Klein

|May 18, 2021

Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist.

Benjamin Berger, Jasper Dingemanse, Giancarlo Sabattini

|Nov 18, 2020

Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Benjamin Berger, Sander Brooks, Rob Zuiker

Pageof 2

Frequent Collaborators

7 joint publications

Jasper Dingemanse

4 joint publications

Priska Kaufmann

3 joint publications

Clemens Muehlan

1 joint publications

Sander Brooks

1 joint publications

Rob Zuiker

1 joint publications

Muriel Richard

1 joint publications

Urs Duthaler

1 joint publications

Stephan Krähenbühl

1 joint publications

Marion Anliker-Ort

1 joint publications

Alexander Treiber

Frequent Collaborators

7 joint publications

Jasper Dingemanse

4 joint publications

Priska Kaufmann

3 joint publications

Clemens Muehlan

1 joint publications

Sander Brooks

Top Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on : Feb 11, 2019

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on : Nov 15, 2013

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

See more related videos

Top Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on : Feb 11, 2019

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on : Nov 15, 2013

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

See more related videos